March 2011 CERN, Geneva European Training Network for Particle Therapy Founded by the European Commission PARTNER.

Slides:



Advertisements
Similar presentations
Heavy Ion Cancer Therapy
Advertisements

MedAustron – Austrian Hadron Therapy Centre
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
D.G.Lewis Department of Medical Physics Velindre Cancer Centre Whitchurch, Cardiff RT-GRID: Grid Computing for Radiotherapy.
Radiobiology Annelie E. Meijer.
Technical studies for the HIE- ISOLDE Frontend upgrade Jacobo Montaño Marie Curie Fellow; CATHI Project * The research project has been supported by a.
Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Radiation oncology at JINR in brief Dzhelepov Laboratory of Nuclear Problems Joint Institute for Nuclear Research, Dubna, Russia  Accelerator technique.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Mid Term Review Meeting, 26 September 2012S. GIRON1 * The research project has been supported by a Marie Curie Early Initial Training Network Fellowship.
TRAINING COURSE ON RADIATION DOSIMETRY: Radiobiology Basics – RBE, OER, LET Anthony WAKER University of Ontario Institute of Technology Thu. 22/11/2012,
Heavy Ion Tumor Therapy
EURATOM RESEARCH AND TRAINING ON NUCLEAR ENERGY 1.
FFAG Fixed Field Alternating Gradient synchrotrons, FFAGs, combine some of the main advantages of both cyclotrons and synchrotrons:  Fixed magnetic field.
Challenges for TPS Chunhua Men Elekta Software, Treatment Planning System BIRS Workshop Banff, Canada 3/12/2011.
ROAD TRANSPORT RESEARCH, TECHNOLOGICAL DEVELOPMENT AND INTEGRATION (2003 Call)
IT-DNG meeting, CERN , Motivation Project Overview Grid services Status Faustin Laurentiu Roman CERN / IFIC
Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
First Year Workshop 2014 Miriam Lafiandra
08 November 2006ENLIGHT++ for KnowARC project1 ENLIGHT ++ Proton and Ion Therapy “e”-infrastructure for health; “e” for “enhanced, enabled, excellent”
24 September 2008 ENLIGHT, ESF Workshop-Oxford European Network for Light Ion Therapy ENLIGHT Manjit Dosanjh ENLIGHT Coordinator & CERN.
Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
From Physics to Health applications: challenges and benefits Serbia Detector School, 13 September 2014 Manjit Dosanjh, CERN.
1 Dosimetric Optimization of Interstitial Gene Therapy Delivery Systems The Gynecologic Disease Program 1 Georgetown University Med. Ctr. 2 Walter Reed.
Training Module 3 – Version 1.1 For Internal Use Only ® Radiation Therapy 
1 1 contribution in NA4 (Medical applications), EGEE2 Scientific Contributors: F. Bellet H. Benoit-Cattin, deputy P. Clarysse L. Guigues C. Lartizien I.
Building the Europe of Knowledge Proposals for the 7 th Research Framework Programme
ATTRACT – From Open Science to Open Innovation Information Sharing Meeting Brussels, June 19, 2014 Markus Nordberg (CERN) Development and Innovation Unit.
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
ENLIGHT- PARTNER Meeting, June 2009, IFIC- Valencia Manjit DOSANJH ENLIGHT Coordinator & CERN.
Cancer Therapy and Imaging Cancer Therapy and Imaging Rob Edgecock STFC Rutherford Appleton Laboratory.
CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a wide variety of applications Cancer Therapy and UK Activities.
Physics of carbon ions and principles of beam scanning G. Kraft Biophysik, GSI, Darmstadt, Germany PTCOG43 Educational Satellite Meeting: Principles of.
USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.
TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.
Mid Term Review Meeting, 26 September 2012D. Lanaia1 * The research project has been supported by a Marie Curie Early Initial Training Network Fellowship.
Mid Term Review Meeting, 26 September 2012J. MONTAÑO1 * The research project has been supported by a Marie Curie Early Initial Training Network Fellowship.
Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation BE-KT Innovation Day,
ENLIGHT,12/2/20021 Health and Science, can CERN contribute? The Mission of CERN (1954): “The Organization shall provide for collaboration among European.
Comparison of MC and TP Dosimetry Simulations for Cancer Treatment Raymond Mumme May 12, 2014 Supervisor: Thiago Lima (PhD student) Head Supervisor: Dr.
Mid Term Review Meeting, 26 September 2012M.AUGUSTIN1 * The research project has been supported by a Marie Curie Early Initial Training Network Fellowship.
Karolina Kokurewicz Supervisors: Dino Jaroszynski, Giuseppe Schettino
Radiotherapy Physics Chris Fox Department of Physical Sciences Peter MacCallum Cancer Centre.
T. Fleck, GSI, Darmstadt, Germany ICALEPCS Status of the Control System for HICAT at an advanced stage of Commissioning Functions, Restrictions.
Hartmut Eickhoff, GSI 1 Developments in Hadrontherapy -the role of Basic Research Institutes H. Eickhoff GSI/Darmstadt.
IFIC Grid Course, Valencia , Particle Therapy Motivation Project description Legal and ethical framework Status Faustin.
WP4: Applications of Accelerators AccApplic  WP4: Applications of Accelerators  The applications  Current workshops  Future workshops  Plans EuCARD-2.
The Australian Hadron Therapy and Research Facility.
HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,
April 17, Dejan TrbojevicFFAG07 -Non-Scaling FFAG gantries1 Non-Scaling FFAG Gantries Introduction: Motives: The most challenging problem in the carbon/proton.
1 NANO AMPLIFIED THERAPY INFN-Milano, INFN-Torino, INFN-Pisa, INFN- Roma3, CNR-Pisa, University of Torino - Biotechnology Department.
RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016.
Plans and Activities at CERN
Progress in the Application
Combined effect of charged particles irradiation and anticancer drugs in cultured tumor cells.(RDH_IRPT WP2; INFN_Milano, CNAO and Istituto Tumori) The.
BEAT_PRO Beam Tailoring and procedures optimization for clinical bnct
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
Closeout of VHEE17 Workshop
Dr. Chinedu Simeon Aruah MD,MPH, FWACS
Presentation of the health pole Philippe Laniece (IMNC)
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
Figure 6 Double opposed-field irradiation of an idealized geometry
Giulio Magrin, TERA Foundation, Manjit Dosanjh, ENLIGHT++, CERN
Nanoparticles for enhancing the effectiveness of proton therapy
Presentation transcript:

March 2011 CERN, Geneva European Training Network for Particle Therapy Founded by the European Commission PARTNER

March Some facts about cancer and hadron therapy Treatment with hadrons is a promising treatment strategy with large future potential.  Cancer is the second most frequent cause of death in Western societies.  About 50% of patients with cancer undergo radiotherapy in the course of their treatment.  Not all cancers can be treated with a satisfying outcome.  Hadron therapy uses particle beams (i.e. mostly proton and carbon ions) to treat tumours located near critical organs and tumours that respond poorly to conventional radiation therapy.  Hadrons have advantageous dose distributions and increased biological effectiveness. Source: GSI

March to a clinical standard from pilot projects … Hadron therapy centers in Europe Source: EBG MedAustron

March training 24 young researchers For this we still need photos of the missing researchers! PARTNER is …

March a European Commission FP7 Initial Training Network (2008 – 2012) … working on a wide range of disciplines related to hadron therapy... a pan-European network... focussing on intensive and multi-disciplinary training... under the umbrella of together with other EC projects related to HT Enter Vision PARTNER is … TopicLocation Detectors and Accelerators applied in MedicineIFIC, Valencia Leadership CourseUNIS, Guildford Radiobiological Hands-on-trainingGSI, Darmstadt Hadrontherapy Today and Tomorrow and GRID technologiesCERN, Geneva RadiobiologyKI, Stockholm Treatment PlanningMedAustron, Wiener Neustadt and Vienna Clinical TrialsCNAO, Pavia Mathematical ModellingUNIS, Guildford ……

March 2011 PARTNER is …... a collaboration

March 2011 Clinical Studies and Epidemiology Investigating the clinical outcome of hadrontherapy for a wide range of cancer types tumour control overall survival quality of life Clinical Studies and Epidemiology Investigating the clinical outcome of hadrontherapy for a wide range of cancer types tumour control overall survival quality of life Simulations, Dosimetry and Treatment Planning Improving treatment planning Measurements of physical quantities Development and tuning of physics simulation codes Simulations, Dosimetry and Treatment Planning Improving treatment planning Measurements of physical quantities Development and tuning of physics simulation codes Image Guided Hadrontherapy and PET Prototype High-tech systems for optimizing patient treatment increasing the accuracy in localization of the tumour Image Guided Hadrontherapy and PET Prototype High-tech systems for optimizing patient treatment increasing the accuracy in localization of the tumour Information and Communications Technologies and Networking Common tools for promoting collaboration in research and treatment strategies in European hadrontherapy centres towards the creation of a prototype GRID test-bed for hadrontherapy Information and Communications Technologies and Networking Common tools for promoting collaboration in research and treatment strategies in European hadrontherapy centres towards the creation of a prototype GRID test-bed for hadrontherapy Novel Accelerator and Gantry Studies Design and development of new technologies for clinical requirements affordable cost reduced dimensions optimal performance Novel Accelerator and Gantry Studies Design and development of new technologies for clinical requirements affordable cost reduced dimensions optimal performance Radiobiology Experiments elucidating the underlying biological mechanisms of hadrontherapy to increase the treatment effectiveness while protecting healthy tissue Radiobiology Experiments elucidating the underlying biological mechanisms of hadrontherapy to increase the treatment effectiveness while protecting healthy tissue Research in the frame of PARTNER…

March Software platform for evaluating combined modality treatment plans The featurelet approach Deformable Registration algorithmThe image deformation field Image-Guided Hadron Therapy – Siemens Workflow of ‘treatment plan of the day’ adaptive strategy Online adaptive strategy to mitigate the effect of inter-fractional motion The deformation field applied to the delivered dose Valentina Zambrano Wenjing Chen Retrospective treatment planning study on prostate cancer cases rectum bladder prostate Region of interest (grey part) for similarity comparison Image Guided Hadrontherapy and PET Prototype

March 2011 Application of PET imaging in light ion therapy PET prototype for in-situ monitoring Brahme 2009 Development of innovative detector modules based on Multi-gap Resistive Plate Chambers (MRPC), using improved technologies over designs for High Energy Physics. Production of therapeutically useful positron emitter beams during carbon ion deceleration Selection of the optimal target material for 11 C beam production Marta Lazzeroni David Watts Brahme 2009 Image Guided Hadrontherapy and PET Prototype

March An interdisciplinary field that studies the biological effects of ionizing radiation, like: 1.Biophysical properties: LET and RBE We are assessing the relative biological effectiveness (RBE) for different ions for a range of LET values in different cell lines 2. Hypoxia and oxygen enhancement ratio (OER) Hypoxia causes resistance to low-LET radiation We are reproducing different hypoxic status by using specially designed chambers, and estimating the relative OER 3. Particle beams and cell cycle response We are trying to understand the molecular pathways leading to cell cycle alterations and identify the intracellular targets responsible for variation in radiosensitivity Radiobiology

March DNA damage and mechanisms of cell death We are investigating the different types of cell death (e.g. apoptosis, necrosis, mitotic catastrophe, autophagy and senescence), and chromosome aberrations 5. Combination with chemotherapy We are assessing the suitability of particle beam irradiation for combination with other therapeutic modalities such as chemotherapy (e.g. temozolomide) Binucleated with micronuclei Mono-nucleated with micronuclei Apoptotic, mitotic cells and cells with micronuclei Chitralekha Mohanty Katarzyna Zielinska-Chomej Thanks to... Walter Tinganelli Ming Chew Lara Barazzuol …Radiobiology

March 2011 : Objective: Participate in the conceptual design for the development of novel carbon ion gantry machine. To irradiate the tumor tissue from any direction with a carbon ion beam. Reduce size, weight and power consumption of the carbon ion gantry machine. Development of technical aspects of the Magnets to be used in the conceptual gantry design. Motivations The challenge Why Why is this an important subject? The magnets are the main elements which guide the ion beam into the gantry structure The magnets are the main elements which guide the ion beam into the gantry structure. Novel Accelerator and Gantry Studies

March 2011 Objective Development of a linear accelerator (linac) for a carbon ion cyclinac (CABOTO). Motivation… The challenge! Work description: - Performance optimization of CABOTO. - Tests of single-cell accelerating cavites to determine the highest reliable operational gradient for CABOTO. - Comparison between RF linacs and FFAGs for hadrontherapy To deliver a compact, dedicated accelerator, providing the best possible treatment modalities for hadrontherapy at the lowest cost. Machine dimensions could be reduced if high gradients could be achieved in the linac without compromising machine reliability. Cyclotron (injector) Linac (booster, beam energy modulation) Cyclinac Novel Concept Accelerators for Hadrontherapy and Gantry Studies

March 2011 … measurements for hadron therapy o Dosimetric o Microdosimetric o Nuclear fragmentation Objective: Improve treatment by … Simulation, Dosimetry and Treatment planning

March 2011 … treatment planning (TP) system support and benchmarking o Integration of measured data into TP systems o Development of Monte Carlo-based tools for TP o Validation and improvement of MC physics models … Adaptive Radiotherapy (ART) o Use of repeated cone beam CT for adaption of TP Objective: Improve treatment by … Bladder and rectum variation on different treatment days Simulation, Dosimetry and Treatment planning

March 2011 Subject: Development of clinical studies in diseases potentially treatable by hadrotherapy Role: Evaluate efficacy of hadrontherapy on patients with different tumor types treated in the European hadrontherapy facilities. Jeffrey Tuan, Anurita Srivastava Clincial Studies and Epidemiology

March 2011 No computing infrastructure connecting the emerging EU hadron therapy centres for: Situation Grid computing links distributed resources used in a multi- disciplinary virtual organisation. ETOILE (Lyon) HIT (Heidelberg) CNAO (Pavia) MedAustron (Wiener Neustadt) Prototype Cross-border patient referral Cancer Research IT for Hadrontherapy

March Coming soon... Should we mention PARTNER2?

March 2011 CERN, Geneva19 PARticle Training Network for European Radiotherapy This research project has been supported by a Marie Curie Early Initial Training Network Fellowship of the European Community's Seventh Framework Programme under contract number (PITN-GA PARTNER). Coordination: CERN Thank you for your attention